Introduction
Hepatitis C virus (HCV) internal ribosome entry site (IRES) is a highly structured region that gives the virus an advantage over the host cell mRNAs by selectively attracting a portion of eukaryotic initiation factors (eIFs) which recruits the ribosomal machinery to start translation. [1] Different levels of HCV patients were consistent with chronic active hepatitis (A1-A4) and (F1-F3).
After 9 years of chronic infection the patient had managed to resolve the infection completely for a period of 9 months only then the patient experienced a viral recurrence characterized by high viral load and diverse HCV quasispecies. During the 9 month period of viral resolution, HCV +ve (genomic) strand was assessed concomitantly in the patient's serum and in peripheral blood mononuclear cells along with the amplifi cation of the minus (antigenomic) strand in PBMC in a RT-PCR triple test format. [8] The results of the triple test showed a progressive clearance during this period [ Table 1 ]. After these 9 months of viral clearance the patient suffered a viral recurrence and his viral load increased to 1.5 million copies/mL. Both the HCV core and E1 protein levels detected by enzyme linked immunosorbent assay (ELISA) were signifi cantly low in our patient (2.9 and 2.8 O.D.490 nm; respectively) as compared to levels detected in 25 active chronic HCV patients used as positive controls (>4 O.D. 490 nm, respectively) and 25 normal subjects as negative controls (<4 O.D. 490 nm). The core and E1 levels remained within the range of normal subjects during the 9 month period of viral clearance. However, the patient's core and E1 levels have been shifted to 5 O.D. units (490 nm) concomitantly with the beginning of viral recurrence which signifi es a much more active HCV infection. The patient was not exposed to any invasive surgical or dental maneuvers and did not receive any blood transfusion during or after the 9 month period of viral clearance. However, this may not exclude infection with wild type HCV by other routes.
Total cellular RNA was extracted and reverse transcribed as previously described [8] and the obtained DNA fragment was cloned using cloning kit (Promega, Madison, WI). Seventeen recombinant plasmids were purifi ed and sequenced using the Big Dye terminator method (ABI Foster City, CA). BLAST pair wise alignment was done using the NCBI MEGABLAST http://ncbi.nih.gov/BLAST and the ClustalW program (www.ebi.ac.uk/clustalw). Pair wise alignment against HCV 4a HEMA 51 and multiple alignment of the 5'UTR nucleotide sequence derived from the patient's HCV RNA during the fi rst 9 years of infection against reference of variability exist in the HCV IRES. Some are crucial and their role has been evolutionary while others are conserved in all HCV isolates. [2] Determining the IRES secondary structure is a signifi cant step in identifying its mechanism of action. [3] Structured domains, known as stem-loops II, III, and IV, have been identifi ed based on chemical and enzymatic probing as well as phylogenetic comparisons. [2, 4] It was shown that the HCV IRES folds into a unique three dimensional structure in which functionally important stem loops are exposed, and contained at least two independently folded regions corresponding to 40S and eukaryotic initiation factor-3 (eIF3) binding sites. [5] The correct secondary and tertiary IRES RNA folding is essential for correct binding to cellular proteins. RNA secondary structures have been shown to be very sensitive to mutations and any RNA structural reconformations were shown to cause deleterious effects on function. [6] Prevalence of HCV in Egypt exceeds 18% of its population and most infections are caused by genotype 4. Interest in the HCV IRES has thrived because of its essential role in translation, thus making it an attractive target for new antiviral agents. [7] This study attempts to investigate changes in the sequence of IRES IIId stem loop as one of the viral factors that may cause clearance of the HCV infection. The results showed a GC to AG double mutation at positions 253 and 254 within subdomain IIId which induced shuffl ing of the triplet GGG from the tip of the hexa-nucleotide loop to become partially unexposed in an octa-nucleotide loop which in turn prevents binding to 40S ribosomal subunit. Such mutation was associated with reduced core and E1 protein levels as well as minimal infl ammatory activity which subsequently ended up with viral clearance. A viral recurrence was associated with reversion of the mutation to the prototype sequence and elevation of HCV RNA and structural proteins in patient's serum.
Case Report
The patient, who is a clinical laboratory technician, was 16-years-old when he was fi rst tested positive for HCV Abs and HCV RNA by PCR in 2002. Since then, he didn't receive any antiviral therapy for HCV infection, and was diagnosed as a chronic hepatitis C virus patient. The patient had HCV genotype 4 and the viral RNA levels were consistently moderate during the fi rst 9 years of chronic HCV infection ranging from 145,000-290,000 copies/mL (205,000 ± 37,000 copies/ mL). Histopathological examination of ultrasound guided liver needle biopsy showed minimal infl ammation (A1) and no fi brosis (F0). Ultrasound hepatic investigating did not show any abnormality. Twenty-fi ve patients suffering from chronic hepatitis C were used as positive controls. All patients had elevated ALT 83.8 ± 45.2 IU/mL and AST levels 63.1 ± 26.6 IU/mL. HCV RNA concentrations ranged 738,000 ± 433,000 copies/mL. Histopathological fi ndings Figure 1 ]. The consensus sequence for all REFSEQ HCV sequences plus our sequence was calculated. Conservation plot revealed overall homology, with few mutations relative to the 4a subtype [ Figure 2 ]. The sequence mutations were investigated against other genotype sequences, after which a double mutation in the IIId subdomain was found to be unique for HCV genome.
A BLAST search using the NCBI website tool for our patient's IIId subdomain revealed that a novo mutation at position 254 (in reference to HCV H77 prototype) was not reported before, with another rare mutation at position 253. Determination of suboptimal structures was also done in order to assert more confi dence in our analysis. Using RNAFold software (Vienna package) subdomain IIId was found to have an altered secondary structure for the important apical loop from the control 4a. HEMA 51, thus inducing a Figure 3a and b]. A transition mutation in subdomain IIIe didn't affect the stem loop structure (data not shown). A similar observation was found for the other optimal structure at 50% sub optimality. Folding using the MFold package, RNA mute, and RDMASS also gave similar results (data not shown). Surprisingly sequence analysis of 5'UTR from the patient's HCV RNA obtained after viral recurrence revealed reversion of the dinucleotide mutation at positions 253 and 254 from AG to the wild type GC. Mutational analysis using recently developed RNA mutational analysis server (RDMASS) indicated the importance of nucleotides 253 and 254 for the stability of the structure as shown in [Figure 4 ].
Discussion
The 5'UTR was shown to have a quasispecies distribution with minor modifi cation in its sequence and that these changes lead to dramatic variation in translational activity. [9] It was reported that an insertion has lead to enhanced translational activity up to seven folds. [10] It has been repeatedly shown that translational activity is dependent on genotype. Also, translational activities of IRES are dependent on cell types, thus emphasizing the fact that both cis-and trans-acting factors can affect the catabolite activating protein (CAP) independent translation from this region. Domain IIId has been receiving more attention because of its importance in binding to both host and viral proteins. [11] A model in which 40S and the core proteins compete for binding to this domain has been proposed. It has direct binding contacts with the 40S ribosomal subunit via the triplet GGG located in its apical loop. [12, 13] Our logic for the clearance of the HCV infection after 9 years goes as follows: The dinucleotide mutation disrupted the double stranded Watson-Crick pairing of the stem of the IIId sub domain. This is thought to have deleterious effects on translation because of changes to the secondary structure of the helical region. [2, 11] The structure of the apical loop has changed because of this dinucleotide mutation, with the original triplet GGG shifting to the right so that the last GU pair has become part of the stem [ Figure 3b ] which reduced the binding affi nity to the 40S subunit and caused a gradual decrease in the ability of the virus to effectively translate its proteins and eventual clearance of viremia. Because structure integrity of this loop is crucial for initiation of translation, [2] we conclude that such a change inhibited translation, and thus enabled our patient to gradually clear the fi rst infection as this was the major clone that he initially harbored. Backing up this conclusion is the fact that during the viral recurrence 5'UTR sequence didn't have these mutations, structural protein levels were higher than before, and ALT and AST levels have almost doubled. Our data support a structure-to-function interpretation of the translational misfunction caused by re-conformation of the IIId subdomain. This agrees with the fi ndings of Odreman-Macchioli et al., [6] who concluded that correct folding of the secondary and tertiary elements of the IRES subdomains are critical for effi cient binding of subdomain IIId to the 40S subunit and subdomain IIIb to eIF3. Also, our fi nding are similar to those of El Awady et al., [11] who demonstrated that domain III mutations played important roles in IRES translation activity which inducing signifi cant changes in the course of response to IFN.
Previous studies on the epidemiology of HCV in Egypt indicated a higher HCV clearance rate (50%) as compared www.ijmm.org Indian Journal of Medical Microbiology vol. 33, Supplement 1 S148 to the global rate of viral clearance (~25%). This is the fi rst study on Egyptian viral strains that could help to elucidate some of the viral factors that may be responsible for viral clearance. This case report showed how a genotype variation in an important stem loop of the IRES can induce a direct phenotype change exemplifi ed in the clearance of the virus from the patient. Such critical sequences may be used as therapeutic targets to abolish HCV replication using RNA silencing and/or antisense RNA. Further studies on patients who cleared the infection and analysis of the IRES region is required to assert the conclusion of this report, along with experimental verifi cation of the changes in secondary structure of the IRES's subdomains.
